Nimorazole

Description	Nimorazole significantly improves the effect of radiotherapeutic management of supraglottic and pharynx tumors and can be given without major side-effects. Nimorazole is the only such agent to have shown a significant effect in a randomized controlled trial in head and neck cancer.
Pathways	Microbiology/Virology
Targets	Antiparasitics

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.